Manipulation of the growth potential and carcass composition of domestic animal species. Finding alternatives to repeated growth hormone(GH) injection to boost production efficiency and minimise carcass fatness remains an important target for animal research. This application exploits the two novel approaches to achieve this goal through: 1. the administration of the GH releasing peptides to the neonate to imprint an enhanced GH secretory pattern and feed conversion efficiency during growth ....Manipulation of the growth potential and carcass composition of domestic animal species. Finding alternatives to repeated growth hormone(GH) injection to boost production efficiency and minimise carcass fatness remains an important target for animal research. This application exploits the two novel approaches to achieve this goal through: 1. the administration of the GH releasing peptides to the neonate to imprint an enhanced GH secretory pattern and feed conversion efficiency during growth to maturity and 2. the development of an orally active form of these peptides by conjugation with VitB12 to facilitate intestinal absorption through the VitB12 transport mechanism for delivery to the hypothalamic/pituitary axis of animals nearing maturity.Read moreRead less
Genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery. The aim of this project is to develop vaccines for the control of swine dysentery (pigs) and intestinal spirochaetosis (pigs and chickens). These infections cause important production-limiting diseases for which no effective vaccines are available. We will use whole genomic sequencing of the two causal species of intestinal spirochaetal bacteria, with a bioinformatics-based analysis of the data to identif ....Genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery. The aim of this project is to develop vaccines for the control of swine dysentery (pigs) and intestinal spirochaetosis (pigs and chickens). These infections cause important production-limiting diseases for which no effective vaccines are available. We will use whole genomic sequencing of the two causal species of intestinal spirochaetal bacteria, with a bioinformatics-based analysis of the data to identify potential cell surface structures that will be tested as the basis of new recombinant vaccines. Outcomes will include the development of new commercial products, increased institutional capacity in veterinary vaccine discovery, and ultimately improved animal health and production in rural Australia.Read moreRead less